high dose glutathione therapy stuart Home The Impact of Glutathione Administration

found no neurodevelopmental issues at 2 years in preterm infants who received ketamine during intubation, supporting Allegaert et al.'s advocacy for personalized dosing tailored to pharmacological maturity (167, 189)

military has also flagged BPC-157 as problematic

Author contributions All authors above made substantial contributions to the conception or design of the work or the acquisition, analysis or interpretation of data for the work and drafting the work or revising it critically for important intellectual content and gave final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved

However, other genetic tests can be recommend, see discussion